Reported 1 day ago
Evogene Ltd. has finalized the sale of its ag-biologicals subsidiary, Lavie Bio Ltd., to ICL Group Ltd. This acquisition includes Lavie Bio’s proprietary technology and product pipeline, with no disruption to existing commercial agreements. CEO Ofer Haviv highlighted the move as a pivotal step in enhancing global reach and fostering sustainable agriculture, while ICL’s Dr. Elinor Erez emphasized the benefits of merging resources to strengthen innovation in the ag-biologicals market.
Source: YAHOO